By: Wai Lang Chu, 12-Jul-2010 A new study believes vaccine manufacturers from developing countries may be able to produce a HPV vaccine at a lower cost without infringing on the numerous patents drug makers have taken out on the vaccine technology. The researcher’s findings have particular relevance with India as it shoulders almost 25 per […]
Gardasil Safety: Post-marketing Experience
CONTRAINDICATIONS Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous dose of GARDASIL. WARNINGS AND PRECAUTIONS Syncope Because vaccinees may develop syncope, sometimes resulting in falling with injury, observation for minutes after administration is recommended. Syncope, sometimes associated with tonic-clonic movements and other seizure-like activity, has been reported following vaccination […]
GARDASIL Reexamination Study
This study is currently recruiting participants. Verified by Merck, February 2010 Official Title Re-examination Study for General Vaccine Use to Assess the Safety Profile of GARDASIL in Usual Practice Purpose This survey is conducted for preparing application materials for re-examination under the Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the […]
